Tag Archives: mutations

Gefitinib (Iressa) is better than Standard Therapy in Lung Cancer with EGFR Mutations

Gefitinib (Iressa) is more effective than first-line therapy in improving survival without disease in patients with advanced nonsmall-cell lung cancer (NSCLC) and epidermal growth-factor receptor (EGFR) mutations.  The current study was conducted in 230 patients from 43 centers in Japan, … Continue reading

Posted in Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , , , | Comments Off on Gefitinib (Iressa) is better than Standard Therapy in Lung Cancer with EGFR Mutations